相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ellagic acid prevents monocrotaline-induced pulmonary artery hypertension via inhibiting NLRP3 inflammasome activation in rats
Bing Tang et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
mTOR and vascular remodeling in lung diseases: current challenges and therapeutic prospects
Elena A. Goncharova
FASEB JOURNAL (2013)
Effects of Everolimus in Combination with Sildenafil in Monocrotaline-induced Pulmonary Hypertension in Rats
Sinem Ilgin et al.
CARDIOVASCULAR TOXICOLOGY (2012)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Targeting mTOR Pathways in Human Malignancies
Angelica Fasolo et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Simvastatin attenuates pulmonary vascular remodelling by down-regulating matrix metalloproteinase-1 and-9 expression in a carotid artery-jugular vein shunt pulmonary hypertension model in rats
Jianping Yao et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2012)
An evaluation of sirolimus in renal transplantation
Fabian Halleck et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
Sirolimus-Eluting Stents for Treatment of Infrapopliteal Arteries Reduce Clinical Event Rate Compared to Bare-Metal Stents Long-Term Results From a Randomized Trial
Aljoscha Rastan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Mechanisms of disease: pulmonary arterial hypertension
Ralph T. Schermuly et al.
NATURE REVIEWS CARDIOLOGY (2011)
Cardiovascular Disease and mTOR Signaling
Zhao Zhong Chong et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2011)
5-Year Clinical Outcomes After Sirolimus-Eluting Stent Implantation Insights From a Patient-Level Pooled Analysis of 4 Randomized Trials Comparing Sirolimus-Eluting Stents With Bare-Metal Stents
Adriano Caixeta et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Cellular and Molecular Basis of Pulmonary Arterial Hypertension
Nicholas W. Morrell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease
M. A. Gatzoulis et al.
EUROPEAN RESPIRATORY REVIEW (2009)
Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-/- mice despite severe hypercholesterolemia
Marc A. Mueller et al.
ATHEROSCLEROSIS (2008)
Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome
Nazzareno Galie et al.
DRUGS (2008)
Evaluating operability in adults with congenital heart disease and the role of pretreatment with targeted pulmonary arterial hypertension therapy
Konstantinos Dimopoulos et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Statin therapy, alone or with rapamycin, does not reverse monocrotaline pulmonary arterial hypertension: the rapamcyin-atorvastatin-simvastatin study
M. Sean McMurtry et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in mice
Renate Paddenberg et al.
RESPIRATORY RESEARCH (2007)
Heme oxygenase-1 mediates the protective effects of rapamycin in monocrotaline-induced pulmonary hypertension
HL Zhou et al.
LABORATORY INVESTIGATION (2006)
40-O-(2-hydroxyethyl)-rapamycin attenuates pulmonary arterial hypertension and neointimal formation in rats
T Nishimura et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
分享论文
